Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment

NCT07814872 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.

NCT NCT07814872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07814872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
Lead sponsor
Harvard Medical School (HMS and HSDM)
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
December 31, 2026
Enrollment
30,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, colorectal neoplasms, endometrial neoplasms, glioma, head and neck neoplasms, kidney neoplasms, lung neoplasms, neoplasms (cancer / tumors), ovarian neoplasms, pancreatic neoplasms, stomach neoplasms